• Xantphos

    Xantphos

    Application It is a useful catalyst in many reactions. And FCAD is the only manufacturer globally who can make this material up to MT scale. Ligand used in a synthesis of heterocycles by palladium-catalyzed C-N cross coupling of 3-bromothiophenes with 2-aminopyridines. Also used in a ruthenium-catalyzed alkylation of active methylene compounds with alcohols. Metal chelating
  • Why FCAD Invested in Ionic Liquids?

    Why FCAD Invested in Ionic Liquids?

    Low Melting Point Ever tried melting table salt? You can’t melt it in a kitchen because they have a melting point of 801○C! Table salt can easily be dissolved in water, but cannot be melted. This is due to the presence of cations and anions in salt. They pack well to each other, lose their
  • What are Silver Nanowires?

    What are Silver Nanowires?

    Brief Introduction of Nanowires Nanowires have a number of exciting properties which are not exhibited by 3-D or bulk materials. This is due to the fact that electrons within the nanowires are quantum confined and have energy levels that differ from that of the bulk materials. Nanowires are nanostructures with a diameter  in the order of
  • Watson’s PDHP CAS 34562-31-7, the Secret to Light Yellow Liquid Appearance

    Watson’s PDHP CAS 34562-31-7, the Secret to Light Yellow Liquid Appearance

    In the competitive world of chemical manufacturing, maintaining consistency and meeting precise specifications are essential for success. One compound that highlights these principles is 3,5-Diethyl-1,2-dihydro-1-phenyl-2-propylpyridine, commonly known as PDHP, with the CAS number 34562-31-7. PDHP is a versatile compound utilized in various industrial applications, including rubber additives and catalytic processes. Among its many attributes, Watson's
  • Watson’s Novel CAP Attracts Global Attention in the mRNA Industry

    Watson’s Novel CAP Attracts Global Attention in the mRNA Industry

    Background mRNA vaccines work by delivering mRNA that encodes for an antigen into human cells, where it is translated to produce the corresponding antigen protein, thereby inducing an effective immune response. The stability of mRNA, translation efficiency, and inherent immunogenicity are key to the success of mRNA as a therapeutic. The 5’ cap structure of